Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Lasers are effective and safe for various medical treatments, including cancer, wound healing, and skin conditions.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Restoring microbial balance and using exosome therapies may help treat hair disorders like alopecia and acne.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Normal human melanocytes can avoid cell death through multiple pathways.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

CD44 variant changes start alopecia areata, but don't maintain it.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Ruxolitinib can cause a delayed skin reaction on the nose.

Araliadiol may promote hair growth like minoxidil without being toxic.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

KRTAP2 genes are crucial for hair structure and may impact hair disorders and treatments.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Fucoidan reduces bone cell formation by affecting T-cell activity.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Personalized skin rejuvenation using genomics shows promise but needs more research.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Sericin from silk cocoons could be a promising drug delivery tool, but stability and consistency need improvement.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.